III.Diabetic nephropathyとdiabetic kidney disease(腎臓)

糖尿病性腎症は,糖尿病の合併症の1つとして重要である.しかし近年,糖尿病管理の進歩や患者の高齢化,脂質異常,高血圧ならびに動脈硬化等の併存治療が長期化する症例が増加している背景もあり,古典的(典型的)な経過を示さない症例も増えてきている.そのような背景をもとに“糖尿病性腎臓病(diabetic kidney disease:DKD)”の疾患概念が提唱・使用されるようになっている.しかし,旧来の糖尿病性腎症(diabetic nephropathy)との異同や用語の使い分けについては,未だに明確でない.本稿では,糖尿病性腎症の病態・診断及びDKDの概念について概説する....

Full description

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 108; no. 4; pp. 681 - 687
Main Authors 古市, 賢吾, 和田, 隆志
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 10.04.2019
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.108.681

Cover

Abstract 糖尿病性腎症は,糖尿病の合併症の1つとして重要である.しかし近年,糖尿病管理の進歩や患者の高齢化,脂質異常,高血圧ならびに動脈硬化等の併存治療が長期化する症例が増加している背景もあり,古典的(典型的)な経過を示さない症例も増えてきている.そのような背景をもとに“糖尿病性腎臓病(diabetic kidney disease:DKD)”の疾患概念が提唱・使用されるようになっている.しかし,旧来の糖尿病性腎症(diabetic nephropathy)との異同や用語の使い分けについては,未だに明確でない.本稿では,糖尿病性腎症の病態・診断及びDKDの概念について概説する.
AbstractList 糖尿病性腎症は,糖尿病の合併症の1つとして重要である.しかし近年,糖尿病管理の進歩や患者の高齢化,脂質異常,高血圧ならびに動脈硬化等の併存治療が長期化する症例が増加している背景もあり,古典的(典型的)な経過を示さない症例も増えてきている.そのような背景をもとに“糖尿病性腎臓病(diabetic kidney disease:DKD)”の疾患概念が提唱・使用されるようになっている.しかし,旧来の糖尿病性腎症(diabetic nephropathy)との異同や用語の使い分けについては,未だに明確でない.本稿では,糖尿病性腎症の病態・診断及びDKDの概念について概説する.
Author 古市, 賢吾
和田, 隆志
Author_xml – sequence: 1
  fullname: 古市, 賢吾
  organization: 金沢大学附属病院血液浄化療法部
– sequence: 1
  fullname: 和田, 隆志
  organization: 金沢大学大学院腎臓内科学
BookMark eNo9kDtOw0AQhlcoSISQkj4XcNjxru1xRxReliLRQG2NvbNkneBEdpqUFAjSpOESHCK3oUnnK2CFRzMjfb_0a745FZ1yUbIQ5yCHPoTxRUluRkOQOAwRjkQXEJXnS1Qd0ZXSBy9QqE9Ev65dJrUKAwSlu-IySZJmt71ylPHK5YOSl9NqsaTVdP318mn-8MyZktcD42qmmpvd-_51u3_7aHabM3FsaV5z_3f3xOPN9cP4zpvc3ybj0cQrAIE8FZkw9zHOYm3Qj0PIdEuUtWGUB1paQENBJJktWGTtG2OjGIBRcoszUD0x-ukt6hU9cbqs3DNV65Sq9r45pwf_tPVP9WG2X_jP8ilVaUHqG2o4X98
ContentType Journal Article
Copyright 2019 一般社団法人 日本内科学会
Copyright_xml – notice: 2019 一般社団法人 日本内科学会
DOI 10.2169/naika.108.681
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 687
ExternalDocumentID article_naika_108_4_108_681_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ID FETCH-LOGICAL-j181a-37d6c289b94d82961b47d63ff67c540f18da570eef1f8e42ddf7911e80e570b13
ISSN 0021-5384
IngestDate Wed Sep 03 06:17:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j181a-37d6c289b94d82961b47d63ff67c540f18da570eef1f8e42ddf7911e80e570b13
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/108/4/108_681/_article/-char/ja
PageCount 7
ParticipantIDs jstage_primary_article_naika_108_4_108_681_article_char_ja
PublicationCentury 2000
PublicationDate 2019/04/10
PublicationDateYYYYMMDD 2019-04-10
PublicationDate_xml – month: 04
  year: 2019
  text: 2019/04/10
  day: 10
PublicationDecade 2010
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2019
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 16) Nowak N, et al: Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int 89: 459-467, 2016.
17) Chronic Kidney Disease Biomarkers Consortium Investigators: Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 58: 188-198, 2015.
7) 和田隆志, 湯澤由紀夫監修, 佐藤 博, 他編: 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き. 東京医学社, 2015.
1) Afkarian M, et al: Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 316: 602-610, 2016.
4) Furuichi K, et al: Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol 22: 1046-1051, 2018.
12) Kanazawa Study Group for Renal Diseases and Hypertension: Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care 36: 3655-3662, 2013.
5) Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development: Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol 22: 629-637, 2018.
15) Vaidya VS, et al: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int 79: 464-470, 2011.
18) Niewczas MA, et al: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507-515, 2012.
6) Tervaert TW, et al: Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21: 556-563, 2010.
11) Toyama T, et al: The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One 8: e71810, 2013.
3) Sharma SG, et al: The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8: 1718-1724, 2013.
14) Morita M, et al: Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. Am J Kidney Dis 58: 915-920, 2011.
9) Hoshino J, et al: A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy. PLoS One 13: e0190923, 2018.
2) Qi C, et al: Classification and Differential Diagnosis of Diabetic Nephropathy. J Diabetes Res 2017: 8637138, 2017.
10) Wada T, et al: Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18: 613-620, 2014.
13) Araki S, et al: Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33: 1805-1810, 2010.
8) Furuichi K, et al: Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transplant 33: 138-148, 2018.
19) Gohda T, et al: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23: 516-524, 2012.
References_xml – reference: 6) Tervaert TW, et al: Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21: 556-563, 2010.
– reference: 14) Morita M, et al: Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. Am J Kidney Dis 58: 915-920, 2011.
– reference: 16) Nowak N, et al: Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int 89: 459-467, 2016.
– reference: 5) Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development: Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol 22: 629-637, 2018.
– reference: 10) Wada T, et al: Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18: 613-620, 2014.
– reference: 15) Vaidya VS, et al: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int 79: 464-470, 2011.
– reference: 9) Hoshino J, et al: A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy. PLoS One 13: e0190923, 2018.
– reference: 13) Araki S, et al: Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 33: 1805-1810, 2010.
– reference: 8) Furuichi K, et al: Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transplant 33: 138-148, 2018.
– reference: 7) 和田隆志, 湯澤由紀夫監修, 佐藤 博, 他編: 糖尿病性腎症と高血圧性腎硬化症の病理診断への手引き. 東京医学社, 2015.
– reference: 11) Toyama T, et al: The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One 8: e71810, 2013.
– reference: 19) Gohda T, et al: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23: 516-524, 2012.
– reference: 4) Furuichi K, et al: Clinico-pathological features of kidney disease in diabetic cases. Clin Exp Nephrol 22: 1046-1051, 2018.
– reference: 3) Sharma SG, et al: The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8: 1718-1724, 2013.
– reference: 17) Chronic Kidney Disease Biomarkers Consortium Investigators: Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 58: 188-198, 2015.
– reference: 18) Niewczas MA, et al: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507-515, 2012.
– reference: 1) Afkarian M, et al: Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 316: 602-610, 2016.
– reference: 2) Qi C, et al: Classification and Differential Diagnosis of Diabetic Nephropathy. J Diabetes Res 2017: 8637138, 2017.
– reference: 12) Kanazawa Study Group for Renal Diseases and Hypertension: Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care 36: 3655-3662, 2013.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 2.198797
Snippet 糖尿病性腎症は,糖尿病の合併症の1つとして重要である.しかし近年,糖尿病管理の進歩や患者の高齢化,脂質異常,高血圧ならびに動脈硬化等の併存治療が長期化する症例が...
SourceID jstage
SourceType Publisher
StartPage 681
SubjectTerms バイオマーカー
糖尿病性腎症
糖尿病性腎臓病(DKD)
腎生検
Title III.Diabetic nephropathyとdiabetic kidney disease(腎臓)
URI https://www.jstage.jst.go.jp/article/naika/108/4/108_681/_article/-char/ja
Volume 108
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2019/04/10, Vol.108(4), pp.681-687
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007485360
  issn: 0021-5384
  databaseCode: KQ8
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZKkRAXxK_41x7wqUqJY8exOeEsWXVBRUJqpd5WieNI3UpLhbYHuHFAwKUXXoKH2Lfh0tu-AjN2spsiDrRIq8iyPY5nx5P5nIxnCHmm6thlrFKRS2QdCel0VMKuOXKc2zKx0Frh4eTdt3JnX7w-SA82rqQ9r6WTebVtP_31XMllpAp1IFc8JXsBya4GhQoog3zhChKG6z_JeDwe02JE8yFVRXBtObRbM3eMqQ8A2X2kBQekSI2qu8ajw3oGT4H2s0xHrGihqEphFF_IqOZdk-6jV1pIqjNqUl8YUjOkBVBJpC2gHggZ1phX1EhaCBxBG1poqnPfpKgxVK1ezHrqETUCCzncOUGJY7ecU5NgrY5pXvT76wQGwLtpGD4O_Uf-1n4y-YgGT9zuVQbzX2Vap1ZcfH5eCj08kFflmchwDnnhx8-p4cgfTEGnvrOB39bleO8bhYRF8NwP7zVcsANKcVhqIcfOylDEqqcRovfYlyHtTIsgZIAQfxqnhEmM7TrDo2Ho2rm9ojoX77tdTRPfD-O3ToS_Qu9J14Yn8iZT2BZcTcCYYcaSN-96qFoLjBTXQ2HqXBIB2GWzfhTAVGW6n_QgE4Dh1vSCA0pl6yiCAFk1V3IVpQ29pEOikPZ_DKFskd3n55gFkDeFLU_nLukR3N5NcqPdeg1M4O4W2ZiWt8m13da55A55Ceq0XJx2ijToKdKvzz87FRoEFRq0KrRcfDv7cnr29cdy8f0u2R8Ve8OdqE0wEk0B2JZgXGtpE6UrLWqVaMkqATW8aWRmYSfTMFWXaRY717BGOZHUdZMBOHAqdlBdMX6PbM7ez9x9MojLKrOM28o2TqR1VZUlc1ZaBSY0tZo9IC8C75PjEEVmcgE5P_wf4kfk-lrXHpPN-YcT9wSA9Lx66pfNbybCn6k
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=III%EF%BC%8EDiabetic+nephropathy%E3%81%A8diabetic+kidney+disease%EF%BC%88%E8%85%8E%E8%87%93%EF%BC%89&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%8F%A4%E5%B8%82%2C+%E8%B3%A2%E5%90%BE&rft.au=%E5%92%8C%E7%94%B0%2C+%EF%A7%9C%E5%BF%97&rft.date=2019-04-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=108&rft.issue=4&rft.spage=681&rft.epage=687&rft_id=info:doi/10.2169%2Fnaika.108.681&rft.externalDocID=article_naika_108_4_108_681_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon